🇺🇸 MRK — Merck & Co., Inc.

Healthcare Compra
← Volver

Precio actual

150,33 USD

Máx. histórico

156,92

10 días

Split 1048:1000 del 03/06/2021

Caída desde máximo

-4,20%

Rango 52 semanas

77,58 – 156,92

Variación hoy

-1,32%

Cierre anterior

152,34

Rango de hoy

150,09 – 152,22

Volumen hoy

4.298.143

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
120,26 (puede no estar actualizado)
Dividend yield
2,23% (puede no estar actualizado)
Precio objetivo analistas
149,50 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 3 días
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,3600 USD · Yield: 2,24%
Fecha de pago Importe por participación
13/06/2011 0,3626 USD
11/03/2011 0,3626 USD
13/12/2010 0,3626 USD
13/09/2010 0,3626 USD
11/06/2010 0,3626 USD
11/03/2010 0,3626 USD
11/12/2009 0,3626 USD
02/09/2009 0,3626 USD
04/06/2009 0,3626 USD
04/03/2009 0,3626 USD
03/12/2008 0,3626 USD
03/09/2008 0,3626 USD
04/06/2008 0,3626 USD
05/03/2008 0,3626 USD
05/12/2007 0,3626 USD
Splits Registrados en el histórico de precios
Fecha Ratio
03/06/2021 1048:1000
17/02/1999 2:1
26/05/1992 3:1
26/05/1988 3:1
27/05/1986 2:1
01/06/1972 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
10/05/2012 36,55 36,85 36,50 36,63 +0,79% 0,97% 9.906.430
09/05/2012 36,58 36,73 36,35 36,35 -1,40% 1,04% 12.539.844
08/05/2012 36,76 36,89 36,53 36,86 +0,23% 0,99% 9.183.205
07/05/2012 36,75 37,03 36,74 36,77 -0,77% 0,80% 12.129.238
04/05/2012 37,32 37,32 36,84 37,06 -0,84% 1,28% 12.505.155
03/05/2012 37,51 37,58 37,27 37,38 -0,31% 0,81% 11.076.731
02/05/2012 37,52 37,62 37,30 37,49 -0,20% 0,86% 12.082.182
01/05/2012 37,16 37,69 37,08 37,57 +0,33% 1,64% 15.290.320
30/04/2012 36,87 37,65 36,82 37,44 +2,03% 2,25% 20.759.413
27/04/2012 37,02 37,16 36,58 36,70 -0,03% 1,55% 16.259.196
26/04/2012 36,72 36,79 36,54 36,71 +0,10% 0,70% 10.683.731
25/04/2012 36,55 36,73 36,38 36,67 +0,42% 0,94% 13.457.054
24/04/2012 36,58 36,67 36,42 36,52 +0,00% 0,68% 13.084.699
23/04/2012 36,78 36,79 36,45 36,52 -1,19% 0,93% 11.183.522
20/04/2012 36,56 37,10 36,55 36,96 +0,96% 1,51% 15.591.306
19/04/2012 36,78 36,85 36,41 36,60 -0,10% 1,19% 11.256.358
18/04/2012 36,68 36,83 36,62 36,64 -0,29% 0,57% 8.033.339
17/04/2012 36,36 36,77 36,25 36,75 +1,48% 1,44% 11.738.019
16/04/2012 36,15 36,32 36,15 36,21 +0,45% 0,48% 14.607.129
13/04/2012 36,35 36,36 36,04 36,05 -1,28% 0,87% 21.859.289
12/04/2012 36,94 36,94 36,44 36,52 -0,55% 1,34% 13.421.107
11/04/2012 36,84 36,93 36,64 36,72 +0,08% 0,78% 11.224.709
10/04/2012 36,94 37,11 36,69 36,69 -0,72% 1,14% 14.655.337
09/04/2012 36,81 37,19 36,79 36,96 -0,39% 1,09% 12.287.066
05/04/2012 36,98 37,13 36,82 37,10 -0,05% 0,83% 14.547.078
04/04/2012 36,83 37,17 36,74 37,12 +0,46% 1,17% 15.940.918
03/04/2012 36,78 36,95 36,70 36,95 +0,55% 0,67% 11.473.609
02/04/2012 36,55 36,79 36,46 36,75 +0,29% 0,91% 11.990.063
30/03/2012 36,39 36,66 36,31 36,64 +1,03% 0,97% 14.794.302
29/03/2012 36,42 36,55 36,05 36,27 -0,78% 1,36% 18.432.434